Welcome to our dedicated page for DALRADA FINCL news (Ticker: DFCO), a resource for investors and traders seeking the latest updates and insights on DALRADA FINCL stock.
Dalrada Financial Corporation, through its subsidiaries, provides various products and services in the manufacturing, engineering, and healthcare sectors worldwide. The company offers low-carbon heating and cooling systems, visual inspection kits for detecting cervical cancer, and software solutions in test engineering, accessibility engineering, and more. Additionally, it provides cleaning solutions with electrostatic machines for various facilities. Formerly known as Imaging Technologies Corporation, Dalrada Financial Corporation was incorporated in 1982 and is headquartered in Escondido, California.
The company, under the leadership of CEO Brian Bonar, focuses on driving innovation in the Clean Energy and Health Care sectors. Its segments include Dalrada Climate Technology and Genefic Specialty Pharmacy, offering advanced heat pump technology and end-to-end prescription services, respectively. With a commitment to sustainability and cutting-edge solutions, Dalrada Financial Corporation aims to deliver value to its shareholders.
Dalrada Financial Corporation (OTCQB: DFCO) has appointed Dr. Elizabeth Ann Winzeler to its Dalrada Health advisory board. Dr. Winzeler's expertise in antimicrobial drug discovery is expected to enhance the company's healthcare initiatives. Dalrada aims to implement a national healthcare model, including traditional clinics and telemedicine, and plans to expand into the pharmaceutical sector rapidly. CEO Brian Bonar emphasizes the impact of Dr. Winzeler's experience on accelerating growth in the pharmaceutical market.
Dalrada Financial Corporation (OTCQB: DFCO) has expanded its executive team by appointing Brian McGoff as President and Chief Operating Officer. McGoff brings over 25 years of experience from reputable companies, emphasizing strategies for domestic and international growth. Chairman Brian Bonar welcomes him as a catalyst for driving growth and aligning products across Dalrada's sectors. McGoff aims to enhance business outcomes in health and clean energy, leveraging his extensive industry network and experience in diverse business operations.
Dalrada Corporation (DFCO) announced the acquisition of Watson Rx Solutions, Inc., marking a significant step in its growth strategy within the healthcare sector. This acquisition aims to develop a comprehensive healthcare solution by integrating pharmacy services with a range of patient care offerings, including telemedicine and testing facilities. CEO Brian Bonar emphasized the acquisition's potential to enhance patient care and expand Dalrada's healthcare footprint. The U.S. pharmaceutical market, valued at $300 billion in 2020, presents substantial growth opportunities.
Dalrada Corporation (OTCQB: DFCO) reported record financial growth for Q3 2022, achieving revenue of $5,592,150, a 252% increase from Q3 2021's $1,588,329. For nine months, revenue reached $15,641,766, up 458% year-over-year. The surge is primarily due to the COVID-19 testing segment and the sale of Likido® products. The company signed five contracts under its new Dalrada Energy Services division, promising further revenue growth. Major accomplishments include validation of Likido®ONE heat pumps by U.S. authorities and expansion in sales, positioning Dalrada for ongoing success.
Dalrada Corporation (OTCQB: DFCO) announced that its Likido®ONE heat pump has been selected by the US General Services Administration and Department of Energy for evaluation under the Green Proving Ground program. This initiative aims to reduce greenhouse emissions from commercial buildings. The Likido®ONE is a CO2-based heat pump that enhances efficiency and decarbonizes heating, addressing climate change challenges. Dalrada's technology aligns with federal efforts to adopt clean energy solutions while potentially reducing operational costs for commercial spaces.
Dalrada Corporation (OTCQB: DFCO) has successfully completed a second clinical trial of its cerVIA™ kit for cervical cancer screening in India, involving 100 women. The study faced delays due to COVID-19, with results published in the IJOPARB Journal. This trial showed the kit's accuracy at 91%, contributing to a significant public health goal: the WHO's aim to eliminate cervical cancer by 2030. The cerVIA™ kit is designed to enhance accessibility and reduce hospital visits, operational during a time when cancer screenings have notably declined globally.
Dalrada Corporation (OTCQB: DFCO) has announced the appointment of Nick Gordon to its Board of Directors. Gordon, with extensive experience in real estate investments, will enhance Dalrada's market presence in clean energy and the hospitality sector. His background includes co-founding several companies and a strong track record with leading firms. Dalrada aims to leverage his expertise to implement Environmental, Sustainability, and Governance (ESG) compliance, boosting property values and driving cost savings through innovative technologies like the Likido®ONE heat pump.
Dalrada Corporation (OTCQB: DFCO) announces the appointment of Phil Marriott to its Board of Directors, enhancing its leadership with his 50+ years of hospitality and real estate experience. Mr. Marriott's expertise will aid Dalrada's subsidiary, Dalrada Energy Services, in implementing Environmental, Sustainability, and Governance (ESG) solutions in the global hospitality industry. These initiatives focus on reducing fossil fuel reliance and achieving significant cost savings through innovative technologies like the Likido® heat pump.
Dalrada Corporation (DFCO) announces the acquisition of Remedi Med Spas, adding two new Sòlas Rejuvenation + Wellness locations in Southern California. The Coronado Island and Mission Hills locations will enhance Dalrada Health's service offerings. Dr. Rakhesh Guttikonda will serve in an advisory role, leveraging his expertise in plastic and reconstructive surgery. This expansion aims to provide residents with alternative health therapies alongside surgical treatments, thereby strengthening Dalrada's position in the healthcare sector.
FAQ
What is the current stock price of DALRADA FINCL (DFCO)?
What is the market cap of DALRADA FINCL (DFCO)?
What products and services does Dalrada Financial Corporation offer?
When was Dalrada Financial Corporation incorporated?
Where is Dalrada Financial Corporation headquartered?
Who is the CEO of Dalrada Financial Corporation?
What are the core segments of Dalrada Financial Corporation?
What is the focus of Dalrada Financial Corporation?
What is the mission of Dalrada Financial Corporation?
